Han, K. S., Li, N., Raven, P. A., Fazli, L., Frees, S., Ettinger, S., . . . So, A. I. (2015). Inhibition of endoplasmic reticulum chaperone protein glucose-regulated protein 78 potentiates anti-angiogenic therapy in renal cell carcinoma through inactivation of the PERK/eIF2α pathway. Oncotarget.
シカゴスタイル引用形Han, Kyung Seok, et al. "Inhibition of Endoplasmic Reticulum Chaperone Protein Glucose-regulated Protein 78 Potentiates Anti-angiogenic Therapy in Renal Cell Carcinoma Through Inactivation of the PERK/eIF2α Pathway." Oncotarget 2015.
MLA引用形式Han, Kyung Seok, et al. "Inhibition of Endoplasmic Reticulum Chaperone Protein Glucose-regulated Protein 78 Potentiates Anti-angiogenic Therapy in Renal Cell Carcinoma Through Inactivation of the PERK/eIF2α Pathway." Oncotarget 2015.